Qritive selected among the top 20 companies to participate in the prestigious MedTech Innovator Asia Pacific Accelerator 2024 program

We are pleased to share that Qritive was selected among the top 20 companies to participate in the MedTech Innovator Asia Pacific Accelerator 2024 program. MedTech Innovator, the world’s largest accelerator of medical technology companies, chose us from over 400 applicants for this year’s Asia Pacific program. This selection highlights our commitment to advancing medical technology and transforming patient care. We had the opportunity to join a cohort of innovators and engage with investors, business leaders, and industry professionals at the Innovator Summit 2024 in San Francisco on June 12-13. Our experience at the MedTech Innovator Summit 2024 in Mountain View, California, was enriching. The 2-day program included insightful content, activities, and connections. We appreciate the chance to meet and reconnect with many talented individuals who are transforming healthcare. Well done to the organizing team, our fellow members of #MTIAPAC, and all the participating startups. Thank you to MedTech Innovator and all the sponsors and partners for this opportunity. Together, we aim to drive the commercialization of life-changing technologies in the region and beyond.